Cargando…
Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic
Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003983/ https://www.ncbi.nlm.nih.gov/pubmed/33800980 http://dx.doi.org/10.3390/ijerph18063234 |
_version_ | 1783671817869721600 |
---|---|
author | Sánchez-García, Juan Carlos Cortés-Martín, Jonathan Rodríguez-Blanque, Raquel Marín-Jiménez, Ana Eugenia Montiel-Troya, Maria Díaz-Rodríguez, Lourdes |
author_facet | Sánchez-García, Juan Carlos Cortés-Martín, Jonathan Rodríguez-Blanque, Raquel Marín-Jiménez, Ana Eugenia Montiel-Troya, Maria Díaz-Rodríguez, Lourdes |
author_sort | Sánchez-García, Juan Carlos |
collection | PubMed |
description | Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group. |
format | Online Article Text |
id | pubmed-8003983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80039832021-03-28 Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic Sánchez-García, Juan Carlos Cortés-Martín, Jonathan Rodríguez-Blanque, Raquel Marín-Jiménez, Ana Eugenia Montiel-Troya, Maria Díaz-Rodríguez, Lourdes Int J Environ Res Public Health Article Scientific knowledge on depression and anxiety in patients with rare diseases during the COVID-19 pandemic is scarce; however, it is essential to perform comprehensive management of these patients. The aim of this study was to research how the situation caused by the SARS-CoV-2 pandemic has influenced the lives of patients with rare diseases regarding depression and anxiety. This Spanish study considered a heterogeneous population sample of 86 patients with confirmed diagnosis of different rare diseases. Participants took part in a cross-sectional online study by completing specific questionnaires on the study topic. Depression was measured using the Patient Health Questionnaire (PHQ-9), and the General Anxiety Disorder Scale (GAD-7) was used for evaluating anxiety. Data collection through an online questionnaire allowed for a greater population scope and therefore the inclusion patients of other nationalities in the study sample. Finally, as a general result, this study found that, in the face of the pandemic, anxiety and depression remained at a higher level in this group than in the general population, making these patients a vulnerable population group. MDPI 2021-03-21 /pmc/articles/PMC8003983/ /pubmed/33800980 http://dx.doi.org/10.3390/ijerph18063234 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sánchez-García, Juan Carlos Cortés-Martín, Jonathan Rodríguez-Blanque, Raquel Marín-Jiménez, Ana Eugenia Montiel-Troya, Maria Díaz-Rodríguez, Lourdes Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title | Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title_full | Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title_fullStr | Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title_full_unstemmed | Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title_short | Depression and Anxiety in Patients with Rare Diseases during the COVID-19 Pandemic |
title_sort | depression and anxiety in patients with rare diseases during the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003983/ https://www.ncbi.nlm.nih.gov/pubmed/33800980 http://dx.doi.org/10.3390/ijerph18063234 |
work_keys_str_mv | AT sanchezgarciajuancarlos depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic AT cortesmartinjonathan depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic AT rodriguezblanqueraquel depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic AT marinjimenezanaeugenia depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic AT montieltroyamaria depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic AT diazrodriguezlourdes depressionandanxietyinpatientswithrarediseasesduringthecovid19pandemic |